Upgrade to SI Premium - Free Trial

Portola Pharma (PTLA) Announces European CHMP Adopts Positive Opinion on Ondexxya

March 1, 2019 7:39 AM
Portola Pharmaceuticals, Inc.® (Nasdaq: PTLA) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Management Comments

Next Articles